Runyon B A
J Hepatol. 1986;3(2):219-22. doi: 10.1016/s0168-8278(86)80029-0.
Ascitic fluid fibronectin concentration was measured in 111 specimens by laser nephelometry. Sterile, portal hypertension-related fluid fibronectin concentration (24 +/- 14 micrograms/ml) was significantly lower than the concentration in infected, portal hypertension-related ascites (49 +/- 44 micrograms/ml, P less than 0.001), peritoneal carcinomatosis (123 +/- 45 micrograms/ml, P less than 0.001), massive liver metastases-related ascites (55 +/- 21 micrograms/ml, P less than 0.001), as well as in ascites of other types (94 +/- 42 micrograms/ml, P less than 0.001). The percentage of samples with fibronectin concentration, greater than 75 micrograms/ml, was 0% for sterile, portal hypertension-related ascites, 28% for infected, portal hypertension-related ascites, 89% for peritoneal carcinomatosis, 20% for massive liver metastases-related ascites, and 72% for ascites of other types. Ascitic fluid fibronectin concentration correlated in a linear fashion with ascitic fluid total protein (r = 0.81, P less than 0.001). Fibronectin concentration in ascites appears to be elevated under a variety of conditions and does not appear to be a specific marker for cancer.
采用激光散射比浊法对111份样本的腹水纤维连接蛋白浓度进行了测定。无菌的、与门静脉高压相关的腹水纤维连接蛋白浓度(24±14微克/毫升)显著低于感染性门静脉高压相关腹水(49±44微克/毫升,P<0.001)、腹膜癌转移(123±45微克/毫升,P<0.001)、大量肝转移相关腹水(55±21微克/毫升,P<0.001)以及其他类型腹水(94±42微克/毫升,P<0.001)中的浓度。纤维连接蛋白浓度大于75微克/毫升的样本在无菌的门静脉高压相关腹水中所占百分比为0%,在感染性门静脉高压相关腹水中为28%,在腹膜癌转移中为89%,在大量肝转移相关腹水中为20%,在其他类型腹水中为72%。腹水纤维连接蛋白浓度与腹水总蛋白呈线性相关(r=0.81,P<0.001)。腹水中纤维连接蛋白浓度在多种情况下似乎都会升高,并非癌症的特异性标志物。